Drug Shortage Report for CLADRIBINE INJECTION

Last updated on 2021-01-26 History
Report ID 127210
Drug Identification Number 02319918
Brand name CLADRIBINE INJECTION
Common or Proper name Cladribine Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CLADRIBINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size mg/mL SD Vial, 10 mL
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-10-30
Actual start date
Estimated end date 2020-11-16
Actual end date 2020-11-16
Shortage status Resolved
Updated date 2021-01-26
Company comments Fresenius Kabi Canada Ltd. regrets to advise that due to a delay in shipment, we will be encountering a supply interruption on our Cladribine Injection, 1 mg/mL SD Vial, 10 mL. Please note the product will remain on 100% allocation until stock is depleted. UPDATE Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Cladribine Injection, 1 mg/mL, SD Vial, 10 mL have been released and will be available at all distribution centers across the country early next week November 16, 2020
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-01-26 French Compare
v4 2021-01-26 English Compare
v3 2020-10-31 English Compare
v2 2020-10-27 French Compare
v1 2020-10-27 English Compare

Showing 1 to 5 of 5